Skip to content

Lactic Acidosis During and After Seizures

Lactic Acidosis During and After Seizures

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01833247
Enrollment
12
Registered
2013-04-16
Start date
2012-07-31
Completion date
2014-12-31
Last updated
2017-05-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Epilepsy

Keywords

epilepsy, lactic acid, saliva, postictal

Brief summary

This project looks at the time course of lactic acid rise (if any) after seizures. Salivary and capillary lactic acid are tested. This type of measurement may be useful in signalling the occurrence or recent history of a seizure.

Detailed description

Lactic acid is released from cells during seizures and elevates lactic acid levels in blood and saliva. The time course of this rise is unknown. If lactic acid rises within a few minutes of a seizure, than it might be feasible to develop lactic acid sensors to provide notification of a recent seizure. This could lead to better safety monitoring for people with epilepsy. This study was designed to utilize a commercially available lactic acid sensor (investigators have no connection with the sensor manufacturer and purchased the device at list price) to measure salivary lactic acid levels after a seizure during inpatient video-EEG epilepsy monitoring.

Interventions

None listed

Sponsors

Stanford University
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

1. Age 18-75 inclusive. 2. History of at least one generalized tonic-clonic (grand mal) seizure prior to enrollment in the study. 3. Undergoing monitoring in the Stanford Epilepsy Monitoring Unit.

Exclusion criteria

4. Not pregnant. 5. Inability to understand and sign the consent form. 6. No known history of mitochondrial disease or other metabolic disorders expected to affect blood lactate. 7. No known history of thrombophlebitis or excessive tendency to bleeding. Not on coumadin. Aspirin or anti-platelet agents are not an exclusion. 8. No known peripheral vascular disease affecting blood circulation to the fingers. 9. No painful peripheral neuropathy. 10. No Raynaud's disease or phenomenon.

Design outcomes

Primary

MeasureTime frameDescription
Salivary Lactic Acid Levels With SeizuresWithin 10 minutes of end of the seizureThe investigators will assess the salivary lactic acid within 10 minutes after end of a seizure. Values will consist of lactic acid measurements in saliva , immediately post-seizure. Units of measurement will be mM/L. A positive outcome will be a curve different from a straight line, with a rise and fall of lactate levels. Baseline lactate serum level is expected to be less than 2.2 mM/L.
Capillary Lactic Acid Levels With SeizuresWithin 10 minutes of end of the seizureThe investigators will assess the capillary lactic acid within 10 minutes after end of a seizure. Values will consist of lactic acid measurements in blood, within 10 minutes after the end of a seizure. Units of measurement will be mM/L. Baseline lactate serum level is expected to be less than 2.2 mM/L.
Intravenous Lactic Acid Levels With SeizuresWithin 10 minutes of end of the seizureThe investigators will assess the intravenous lactic acid within 10 minutes after end of a seizure. Values will consist of lactic acid measurements in serum collected by IV, immediately post-seizure. Units of measurement will be mM/L. A positive outcome will be a curve different from a straight line, with a rise and fall of lactate levels. Baseline lactate serum level is expected to be less than 2.2 mM/L.

Countries

United States

Participant flow

Participants by arm

ArmCount
Epilepsy Inpatients
Patients with epilepsy recorded in an inpatient video-EEG monitoring unit after a seizure.
12
Total12

Baseline characteristics

CharacteristicEpilepsy Inpatients
Age, Continuous40.8 years
Ethnicity (NIH/OMB)
Hispanic or Latino
3 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
9 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
3 Participants
Race (NIH/OMB)
Black or African American
0 Participants
Race (NIH/OMB)
More than one race
0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
White
9 Participants
Region of Enrollment
United States
12 participants
Sex: Female, Male
Female
6 Participants
Sex: Female, Male
Male
6 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
0 / 12
serious
Total, serious adverse events
0 / 12

Outcome results

Primary

Capillary Lactic Acid Levels With Seizures

The investigators will assess the capillary lactic acid within 10 minutes after end of a seizure. Values will consist of lactic acid measurements in blood, within 10 minutes after the end of a seizure. Units of measurement will be mM/L. Baseline lactate serum level is expected to be less than 2.2 mM/L.

Time frame: Within 10 minutes of end of the seizure

Population: Data were collected from 6 of the 12 enrolled subjects

ArmMeasureValue (MEAN)Dispersion
Epilepsy InpatientsCapillary Lactic Acid Levels With Seizures5.67 mmol/LStandard Deviation 4.57
Primary

Intravenous Lactic Acid Levels With Seizures

The investigators will assess the intravenous lactic acid within 10 minutes after end of a seizure. Values will consist of lactic acid measurements in serum collected by IV, immediately post-seizure. Units of measurement will be mM/L. A positive outcome will be a curve different from a straight line, with a rise and fall of lactate levels. Baseline lactate serum level is expected to be less than 2.2 mM/L.

Time frame: Within 10 minutes of end of the seizure

Population: Data were collected from one participant

ArmMeasureValue (NUMBER)
Epilepsy InpatientsIntravenous Lactic Acid Levels With Seizures8.6 mmol/L
Primary

Salivary Lactic Acid Levels With Seizures

The investigators will assess the salivary lactic acid within 10 minutes after end of a seizure. Values will consist of lactic acid measurements in saliva , immediately post-seizure. Units of measurement will be mM/L. A positive outcome will be a curve different from a straight line, with a rise and fall of lactate levels. Baseline lactate serum level is expected to be less than 2.2 mM/L.

Time frame: Within 10 minutes of end of the seizure

ArmMeasureValue (MEAN)Dispersion
Epilepsy InpatientsSalivary Lactic Acid Levels With Seizures8.16 mmol/LStandard Deviation 8.88
Post Hoc

Salivary and Capillary Lactic Acid Will be Correlated After a Seizure

Salivary levels of lactic acid is being studied because saliva is more accessible in the outpatient setting than is blood. Concentration of lactic acid in the serum and saliva from each individual subject will be correlated using Pearson's correlation test. We will consider a positive outcome to be a r greater than or equal to 0.5 and significance at p\<0.05.

Time frame: Within 10 minutes of a seizure

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026